Delivery Order SPE2DB24D3013-SPE2DB26FFFRL
- Not listed
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This non-set-aside, firm fixed-price contract is scheduled for completion by October 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,428.06 on September 15, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a $14,428.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. The delivery order represents a typical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TABRECTA 200 mg tablets in quantities of 56 units. This is a firm fixed-price contract with a ceiling value of $14.4K and an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and represents a competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- This federal contract award is for the delivery of Tabrecta 200 mg tablets to the Defense Logistics Agency (DLA). The $6,547.42 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs. The contract has a completion date of November 20, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $13,094.84, is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with an ultimate completion date of October 7, 2024. This delivery order does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive...
- This federal contract award, with a value of $14,428.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025, and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product TABRECTA 200 MG TABLET. The award has a potential value of $6,547.42 and a completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The contract is not set aside for any specific...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,547.42 firm fixed-price delivery order is for the supply of TABRECTA 200 MG TABLET, with a completion date of September 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various government agencies and healthcare programs. This award is not...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFRLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14.4K to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Tabrecta (entinostat) 200 mg tablets in a quantity of 56 units. This firm fixed-price, competitively awarded delivery order is expected to be completed by November 12, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 million and extends through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive portfolio of medications, vaccines, and medical devices across multiple therapeutic domains to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive contract history with DLA demonstrates its established capability to fulfill federal pharmaceutical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 10/21/25 |